ArticleChemSusChem2026
Dual-Doped CoFe Hydroxide Through Chromium and Sulfur Incorporation for Efficient Oxygen Evolution in Alkaline Seawater Electrolysis.
Article in ChemSusChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The oxygen evolution reaction (OER) remains a critical kinetic bottleneck in water electrolysis for sustainable hydrogen production, necessitating the development of efficient and durable electrocatalysts. Herein, a sulfur-incorporation strategy is employed to regulate the activity and stability of CoFeCr hydroxide toward OER in alkaline and seawater environments. Sulfur-incorporated CoFeCr hydroxide (S-CoFeCr-OH) is synthesized via a two-step hydrothermal-sulfurization process, which preserves the nanosheet architecture while enabling uniform sulfur incorporation into the hydroxide lattice without forming inactive sulfide phases. As a result, S-CoFeCr-OH delivers a low overpotential of 289 mV at 10 mA cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.